The CEO said Havas has a “strategy of bolt-on and targeted acquisitions that contributes to our strong momentum, alongside strategic partnerships." ...

DNAHelix leverages the IPG subsidiary’s expertise in healthcare and science communications as well as its considerable work ...

After a quiet summer, bird flu is on the move again, and experts say it poses an escalating threat. Get to know each of these companies by learning about their culture, work/life balance, D&I ...

The year-end dividend is “undetermined” as the company braces for a heavy fourth quarter, when it will book the bulk of its ¥28 billion restructuring costs.

After a quiet summer, bird flu is on the move again, and experts say it poses an escalating threat. While the virus doesn’t appear capable of spreading from human to human, it has killed people ...

Mazur, GM of LillyDirect, breaks down the platform’s new partnership with Walmart and its implications for the pharma ...

Doctors say these study results won’t change how they advise patients and that women should not stop using their birth control.

Novo Nordisk to lower cash-pay prices for Ozempic and Wegovy to $349 a month; J&J buys Halda Therapeutics for $3.05 billion; Trump attacking health insurers underscores rising tensions around ...